Location: Home
  • search
  • go
  • Relate News
  • 12/21/2016Chinese Startup Firm Acquires Harbour Antibodies to Create Global, Onc...
  • 12/19/2016BMJ Expands into Primary Healthcare in China Thru Local Partnership
  • 12/19/2016Ferring Licenses Asian Rights of Autoimmune Disease Drug Olamkicept to...
  • 12/19/2016Drug Registration Approval and Application Update 11/2016
  • 12/16/2016CDE Solicits Comments on Draft Guideline for Research and Review of Ce...
  • 12/16/2016Recent Executive Moves
  • 12/16/2016USFDA Completes Review of First IND for Subcutaneous Inj. Anti-PD-L1 D...
  • 12/16/2016SAIC Fines Southwest No.2 Pharma for API Sales Monopoly
  • 12/16/2016SMEI: Review of Chinese Retail Pharmacy Sales 2013-2015
  • 12/16/2016Review of BMI Fund Operation and Performance in the Past Five Years
  • 12/16/2016CPIIC: Chinese Pharma Industry Forecast to Grow 10.3% and 10.5% in 201...
  • 12/16/2016Recent Judicial Interpretation For Patent Infringement (Effective As O...
  • 12/15/2016Pfizer Enters R&D Partnership with PegBio for Select Diabetes Drug...
  • 12/13/2016Should Big Pharma Be Worried About a Trump Trade War?
  • 12/13/2016Central Government Publishes 2015 Public Hospital Reform Report
  • 12/12/2016CDE Forms Strategic Alliance with the Medical School of Tsinghua Unive...
  • 12/9/2016Fujifilm Expands to Chinese TCM Market Thru Partnership with China Res...
  • 12/9/2016Chinese and Australian Universities Set Up Joint TCM Research Center i...
  • 12/9/2016NDRC, MOFCOM Release Draft Revision of Foreign Investment Industrial G...
  • 12/8/2016Recent Executive Moves
  • 12/8/2016Chi-Med Presents Pre-Clinical Data for Selective Syk Inhibitor HMPL-52...
  • 12/8/2016WSJ: China's Medtronic Fine May Signal Health-Care-Cost Crackdown
  • 12/8/2016Mandarin Capital Acquires Stakes In Italian Drug Firm Mipharm
  • 12/8/2016NHFPC Issues Notice over Implementation of 1,001 Clinical Pathways
  • 12/7/2016NDRC Fines MedTronic CNY 118.5M for Alleged Price-fixing
  • 12/6/2016Pharma MNC's China Performance Rose Only 4% on Average in Q3/2016
  • 12/6/2016BMS Terminates OTC Business Division in China
  • 12/6/2016CFDI Solicits Comments on New Technical Guideline Documents
  • 12/6/2016CDE Seeks Public Comments on Draft Drug Evaluation Document
  • 12/6/2016Zhejiang Huahai’s Unit Buys Charlotte Facility from Par Pharma Subsdi...
  • Page:197/361 Total number of articles:10809: [First][<<] [195] [196] [197] [198] [199] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group